Anil Argilla is the President, Emerging Markets Asia for Pfizer Biopharmaceuticals Group. He is responsible for the entire Pfizer business for Taiwan, Hong Kong, Thailand & Indochina (Laos, Cambodia, Myanmar) Philippines, Indonesia, Malaysia & Brunei, Pakistan, Singapore and Vietnam.

He is currently a Board Member with US ASEAN Business Council; He continues to lead the engagements with Governments across Asia on access to Covid Vaccines/Antivirals and support Governments with their Pandemic Management.

Anil is a well-respected corporate executive and thought leader in the pharmaceutical industry, and a highly experienced professional whose career spans across multiple industries. He is passionate about solving for Equity in Healthcare Access and Digital application in life sciences industry.

He has worked and lived in India, China, Hong Kong, Indonesia and is currently based in Singapore.

With Pfizer, he has handled a diverse range of roles including Cluster Lead Asia, Regional Commercial Lead and Country Manager Indonesia. Prior to joining Pfizer, he was with a management consulting firm focused on organizational transformation and change. His consultancy experience provided him exposure to different industries, including Automobile, IT/ ITES, Banking, Petrochemicals, etc.,

Anil has master’s degree in Personnel Management from Symbiosis Institute of Business Management.and a bachelor’s degree in Commerce from Osmania University.